$AXTI

AXT Jumped Nearly 10% and Has Doubled Since Earnings. Is It Too Late to Buy?

AXT (AXTI) shares rose nearly 10% after its July 30 earnings and have doubled to about $75.17. The article cites Q3 guidance of about $66M revenue and non-GAAP EPS $0.30 to $0.32, plus long-term supply prepayments totaling tens of millions. It highlights export-permit timing risk and a valuation near 47x forward earnings.

Original reporting
Published Aug 7, 2026, 8:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 2:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AXT Jumped Nearly 10% and Has Doubled Since Earnings. Is It Too Late to Buy? — source image
Decision brief

The 30-second read

$AXTINeutralLow
01

Why it matters

The key trading variable is whether the next reported quarter shows revenue clearing the guided $66M secured level, and whether management commentary indicates improving export-permit regularity.

02

Market read

This is primarily a valuation and risk framing of AXTIs post-earnings move, emphasizing that export-permit timing can dominate near-term outcomes despite strong demand signals.

03

What to watch

Some agreements ramp later (for example, Casela starting in 2027), so near-term revenue visibility may be less robust than backlog headlines suggest.

Relevance 4/10Novelty 3/10Timing: into the next quarterly report on October 29

Background

AXTI is a small-cap supplier of indium phosphide substrates used in high-speed lasers and detectors for AI data centers; the article ties its recent surge to post-earnings demand and capacity ramp.

Company-level read

Ticker impact

$AXTINeutralMedium confidence
Context

AXTI shares surged nearly 10% after earnings, with management guiding Q3 revenue to about $66M and highlighting strong indium phosphide demand.

Expected impact

Near-term volatility likely remains high into the next reported quarter, with upside skew if revenue clears the $66M secured level and permit commentary improves.

Evidence & confidence

While the text cites specific guidance, deposits, and permit risk, it is still an analysis piece rather than a fresh disclosure beyond the already-reported earnings and agreements.

Market effects

Highlights how AI optical infrastructure supply chains can trade on constrained specialty materials and export-permit execution, not just demand.

Emphasizes U.S.-China export-permit process risk for shipments leaving China, which can affect delivery schedules and sentiment.

If permit timing improves, it supports broader confidence in AI data-center optical supply availability; if delayed, it can tighten supply expectations.

Counterpoint

The valuation assumes near-flawless execution and smooth permit flow; any single delayed permit quarter could compress the multiple quickly given negative free cash flow and cash-consuming capacity build.

Key entities

  • AXTI

    Indium phosphide substrate supplier whose post-earnings rally is framed as a permit-and-capacity execution bet.

  • Ministry of Commerce (China)

    Export-permit authority whose timing affects shipments leaving China.

  • Casela

    Named in long-term supply agreements with prepayments to AXT.

  • Coherent

    Named in long-term supply agreements with prepayments to AXT.

  • Lumentum

    Named in a capacity-reservation agreement with deposits applied as shipment credits through 2031.

Related articles

$AXTIMedAI 8/10

AXTI Stock Soars As AI Demand Turns Earnings Corner

AXT Inc (NASDAQ: AXTI) shares rose about 18.6% after the company announced semiconductor capacity expansion tied to AI demand. The article cites Q2 revenue of $47.6M (vs $18.0M a year earlier) and adjusted EPS of $0.19. It also reports Q3 guidance EPS $0.30–$0.32 and revenue about $66M, plus analyst target updates.

$AXTIMedAI 8/10

AXT (AXTI) Q2 2026 Earnings Call Transcript

AXT (AXTI) held its Q2 2026 earnings call, reporting revenue of $47.6M, up 77% vs Q1 2026 and 164% vs Q2 2025. Indium phosphide revenue was $30.7M. Non-GAAP gross margin was 45.0%. Non-GAAP net profit was $11.9M ($0.19/share). Cash rose to $749M after a $632M secondary offering. The company also discussed supply prepayments and a plan to list its Tongmei subsidiary via Hong Kong instead of China’s STAR Market.

$AXTIMed

AXT (AXTI) Stock Jumps As AI Demand Fuels Profit Revival

AXT (AXTI) shares rose 28.7% to $60.43 after the company reported Q2 results. According to AXT, Q2 revenue was $47.6m versus $18.0m a year earlier, with net profit of $11.1m versus a loss, and basic EPS of $0.18. Non-GAAP gross margin rose to 45% from 8.2%, driven by indium phosphide revenue and AI demand.

$AXTIHighAI 9/10

AXT Sees Highest Quarterly Indium Phosphide Revenue Ever - AXT (NASDAQ:AXTI)

AXT Inc. (NASDAQ:AXTI) shares rose premarket after the company reported Q2 results. Adjusted EPS was 19 cents, above the 7-cent consensus. Revenue increased 164.8% Y/Y to $47.59 million versus $34.09 million expected. Indium phosphide revenue reached a record $30.7 million, and Q3 guidance calls for adjusted EPS of 30-32 cents and sales of $66.0 million.

$AXTIMedAI 8/10

AXT: Q2 Earnings Snapshot

FREMONT, Calif. (AP) — FREMONT, Calif. (AP) — AXT Inc. (AXTI) on Thursday reported second-quarter net income of $11.1 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Fremont, California-based company said it had net income of 17 cents. Earnings, adjusted for stock option expense, came to 19 cents per share. The results beat Wall Street expectations.

$AXTIHighAI 9/10

AXT Stock Rips Higher After Q2 Earnings — Here's Why - AXT (NASDAQ:AXTI)

Here’s a look at the details inside the report. AXTI stock is moving. Watch the price action here. AXT Q2 Details Semi wafer manufacturer AXT reported quarterly earnings of 19 cents per share, which beat the analyst consensus estimate of seven cents by 171.43%, according to Benzinga Pro data. Quarterly revenue clocked in at $47.59 million, blowing past the Street estimate of $34.09 million by 39.61%.